← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Precision BioSciences DTIL $170M	–	–	–	–
77	77 enGene Therapeutics ENGN $115M	–	–	–	–
78	78 Estrella Immunopharma ESLA $23.3M	–	–	–	–
79	79 FibroBiologics FBLG $7.08M	–	–	–	–
80	80 4D Molecular Therapeutics FDMT $711M	–	–	–	–
81	FRLN 81 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
82	82 DELISTED Generation Bio GBIO	–	–	–	–
83	83 CytoMed Therapeutics GDTC $10.4M	–	–	–	–
84	GMDA 84 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	–	–	–	–
85	85 Genenta Science GNTA $32.3M	–	–	–	–
86	GRCL 86 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
87	GRML 87 Greenland Mines Ltd GRML $92.9M	–	–	–	–
88	88 Fractyl Health GUTS $55.2M	–	–	–	–
89	89 Immix Biopharma IMMX $720M	–	–	–	–
90	90 Immatics IMTX $1.09B	–	–	–	–
91	91 IN8bio INAB $11.7M	–	–	–	–
92	92 MiNK Therapeutics INKT $50.7M	–	–	–	–
93	93 INmune Bio INMB $45.8M	–	–	–	–
94	94 Century Therapeutics IPSC $272M	–	–	–	–
95	KRBP 95 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–
96	96 Kyverna Therapeutics KYTX $369M	–	–	–	–
97	97 Legend Biotech LEGN $3.85B	–	–	–	–
98	LGVN 98 Longeveron LGVN $4.78M	–	–	–	–
99	99 Lunai Bioworks LNAI $3.74M	–	–	–	–
100	LOGC 100 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	–	–	–	–